Soleno Therapeutics
$53.01
55
-$0.00-0% Monday 13:30
Statistics
Day High
53.01
Day Low
52.98
52W High
90.32
52W Low
29.43
Volume
4,968,834
Avg. Volume
3,623,442
Mkt Cap
2.85B
P/E Ratio
27.47
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12AugExpected
Expected EPS
0.918889
Actual EPS
N/A
Financials
10.97%Profit Margin
Profitable380.81MRevenue
41.78MNet Income
Analyst Ratings
59.75Average Price Target
The highest estimate is 80.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 17%
Hold 83%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SLNO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.81B
Sarepta Therapeutics
SRPT
Mkt Cap1.62B
PTC Therapeutics
PTCT
Mkt Cap6.37B
Ultragenyx Pharmaceutical
RARE
Mkt Cap2.4B
Ionis Pharmaceuticals
IONS
Mkt Cap12.11B
Alnylam Pharmaceuticals
ALNY
Mkt Cap37.76B
CRISPR Therapeutics
CRSP
Mkt Cap4.9B
About
Soleno Therapeutics, Inc. (SLNO) operates as a clinical-stage biopharmaceutical company, specializing in the creation and market introduction of groundbreaking treatments for uncommon illnesses. The cornerstone of its therapeutic pipeline is Diazoxide Choline Controlled-Release, a once-daily oral tablet aimed at addressing Prader-Willi Syndrome, currently progressing through an active Phase III clinical evaluation. Established in 1999, the Redwood City, California-headquartered firm adopted its current name, Soleno Therapeutics, Inc., in May 2017, having previously operated as Capnia, Inc.
Show more...
CEO
Dr. Anish Bhatnagar M.D.
Employees
115
Country
United States
ISIN
US8342033094
Listings
0 Comments
Share your thoughts
FAQ
What is Soleno Therapeutics stock price today?▼
The current price of SLNO is $53.01 USD — it has decreased by -0% in the past 24 hours. Watch Soleno Therapeutics stock price performance more closely on the chart.
What is Soleno Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Soleno Therapeutics stocks are traded under the ticker SLNO.
Is Soleno Therapeutics stock price growing?▼
SLNO stock has risen by +0% compared to the previous week, the month change is a -0% fall, over the last year Soleno Therapeutics has showed a -32.17% decrease.
What is Soleno Therapeutics market cap?▼
Today Soleno Therapeutics has the market capitalization of 2.85B
When is the next Soleno Therapeutics earnings date?▼
Soleno Therapeutics is going to release the next earnings report on August 12, 2026.
What were Soleno Therapeutics earnings last quarter?▼
SLNO earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.68 USD resulting in a -13.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Soleno Therapeutics revenue for the last year?▼
Soleno Therapeutics revenue for the last year amounts to 380.81M USD.
What is Soleno Therapeutics net income for the last year?▼
SLNO net income for the last year is 41.78M USD.
How many employees does Soleno Therapeutics have?▼
As of June 16, 2026, the company has 115 employees.
In which sector is Soleno Therapeutics located?▼
Soleno Therapeutics operates in the Health & Wellness sector.
When did Soleno Therapeutics complete a stock split?▼
The last stock split for Soleno Therapeutics was on August 26, 2022 with a ratio of 1:15.
Where is Soleno Therapeutics headquartered?▼
Soleno Therapeutics is headquartered in Redwood City, United States.